United Therapeutics Corporation (UTHR)

NASDAQ
264.23
-1.69(-0.64%)
After Hours
264.00
-0.23(-0.09%)
- Real-time Data
  • Volume:
    246,713
  • Day's Range:
    262.81 - 266.00
  • 52 wk Range:
    158.38 - 283.09

UTHR Overview

Prev. Close
265.92
Day's Range
262.81-266
Revenue
1.44B
Open
266
52 wk Range
158.38-283.09
EPS
15.62
Volume
246,713
Market Cap
12.04B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
385,306
P/E Ratio
16.92
Beta
0.626
1-Year Change
33.07%
Shares Outstanding
45,576,954
Next Earnings Date
Feb 22, 2023
What is your sentiment on United Therapeutics?
or
Market is currently closed. Voting is open during market hours.

United Therapeutics Corporation News

United Therapeutics Corporation Analysis

United Therapeutics Corporation Company Profile

United Therapeutics Corporation Company Profile

United Therapeutics Corporation is a pharmaceutical company. The Company markets and sells four commercial therapies in the United States to treat ulmonary arterial hypertension (PAH): Tyvaso (treprostinil) Inhalation Solution (Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso has also been approved to treat pulmonary hypertension associated with interstitial lung disease. It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin), which is approved for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). It also includes technologies designed supply of transplantable organs and tissues and improves outcomes for transplant recipients through regenerative medicine, three-dimensional (3-D) organ bioprinting, xenotransplantation and ex-vivo lung perfusion.

Read More

Analyst Price Target

Average285.50 (+8.05% Upside)
High375.00
Low150.00
Price264.23
No. of Analysts12
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuyStrong Buy
Technical IndicatorsSellStrong BuyStrong BuyBuyStrong Buy
SummaryNeutralStrong BuyStrong BuyBuyStrong Buy
  • 8/21/20 12:00 PM ET: UTHR looks like a strong bug under $108, while trading 11x earnings.
    0
    • *buy
      1